Definitive Healthcare Corp. (DH) vs Outlook Therapeutics, Inc. (OTLK)
A side-by-side comparison of Definitive Healthcare Corp. and Outlook Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DH
Definitive Healthcare Corp.
$1.00HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
OTLK
Outlook Therapeutics, Inc.
$0.58HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — DH vs OTLK
growth of $100 · dividends reinvested · last 5yDH -97.7% (-53.1%/yr)OTLK -98.8% (-58.5%/yr)DH compounded faster over this window
DH OTLK
DH vs OTLK: by the numbers
- •OTLK is the larger company ($108M vs $105M market cap).
- •Both run net losses; DH's is the smaller (-72.28% vs -4416.22% net margin).
Metrics side by side
Valuation
| Metric | DH | OTLK |
|---|---|---|
| Forward P/E | 5.12 | N/A |
| P/S ratio | 0.45 | N/A |
| P/B ratio | 0.73 | N/A |
| EV / EBITDA | 0.49 | N/A |
| FCF yield | 27.17% | N/A |
Profitability
| Metric | DH | OTLK |
|---|---|---|
| Gross margin | 71.67% | 46.49% |
| Operating margin | -8.52% | -4744.25% |
| Net margin | -72.28% | -4416.22% |
| ROE | -116.28% | N/A |
| ROIC | 41.64% | -352.19% |
Growth (annualized)
| Metric | DH | OTLK |
|---|---|---|
| Revenue CAGR (5Y) | 10.62% | N/A |
| FCF CAGR (5Y) | 2.14% | N/A |
| Total return CAGR (5Y) | -52.54% | -57.40% |
Frequently asked
- How have DH and OTLK total returns compared?
- Over the past 5 years, DH delivered -52.54% and OTLK delivered -57.40% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Definitive Healthcare ROEOutlook Therapeutics ROEDefinitive Healthcare operating marginOutlook Therapeutics operating marginDefinitive Healthcare revenue growthOutlook Therapeutics revenue growthDefinitive Healthcare free cash flowOutlook Therapeutics free cash flow
Definitive Healthcare & Outlook Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.